Abstract:Background Internationally, there is increased interest in reporting, treating and attempting to reduce complications of blood donation. Donor haemovigilance is the systematic monitoring of adverse reactions and incidents in the whole chain of blood donor care, with a view to improving quality and safety for blood donors. International Developments Several studies have described the risk factors for vasovagal reactions – female donors, young age, first‐time status, low body weight, etc. A water drink before donation, use of applied muscle tension and social support during donation have been found effective in reducing minor vasovagal reactions and/or increasing the likelihood of donors returning for subsequent donations. Haematomas and other venepuncture‐related complications are frequent and are the predominant cause of long‐term morbidity from complications of blood donation. International surveillance data on donor complications are captured in ‘ISTARE’ International Surveillance database for Transfusion‐associated Adverse Reactions and Events, which is being developed by the International Hemovigilance Network. Experience in The Netherlands: Better Monitoring of Donor Complications, Where Next? All donor complications and procedural problems are routinely recorded in the computer system eProgesa. Since 2009, the results have been monitored. An improved coding list was introduced in 2010 in order to record more details and cover new procedures such as Rhesus immunizations. The overall rate of donor complications increased from 0·64 in 2009 to 0·80 per 1000 whole blood collections (second half of 2010) and from 1·34 to 1·40 per 1000 plasmaphereses; there were no changes in donor demographics or procedures to explain this, so better recording is presumed. The recorded complications and procedural problems are regularly presented in team leaders’ and regional directors’ meetings. The data have been used to analyse the effect of a procedural modification: increasing the concentration of citrate solution used in plasmapheresis. The rate of terminating procedures because of citrate reactions was 0·14 per 1000 collections [95% confidence interval (CI) 0·018–0·27] before and 0·09 (95% CI 0·018–0·17) after the modification, signifying no relevant change. It is hoped that in 2012 a revised donor information brochure with instructions on avoiding vasovagal reactions will be piloted and subsequently tested. Nevertheless, only immediate and short‐term complications can be effectively addressed by the recording and analysis of complications. Longer term issues such as whole blood donor iron status are the subject of research in our country and abroad. Conclusion In our country as well as elsewhere, recording and monitoring the incidence of complications of blood donation has become the norm. Knowledge of risk factors and evidence‐based interventions will enable blood establishments worldwide to reduce donor complications. As yet, longer term complications are not well addressed.

Blood donation: NHS stocks are still in short supply after June cyberattack

Blood donation: NHS issues urgent appeal amid "unprecedentedly low" stocks

Mitigating the impact of blood shortages in England

Impact of the COVID‐19 outbreak on blood supply in two large university hospitals

How do I manage a blood product shortage?

Blood donations and donors' profile in Lithuania: Trends for coming back after the COVID-19 outbreak

London 2017: Lessons learned in transfusion emergency planning

Supplemental findings of the 2021 National Blood Collection and Utilization Survey

Impact of disasters on blood donation rates and blood safety: A systematic review and meta‐analysis

Changes in transfusion‐transmissible infection prevalence and demographics among US blood donors during the COVID‐19 pandemic

Through the Eyes of the Recipient: Navigating Transfusion Services Amidst COVID-19 in Multi-Transfused Thalassaemic Patients

Safety profile of plasma for fractionation donated in the United Kingdom, with respect to variant Creutzfeldt-Jakob disease

Donor vigilance: progress and challenges

Status of hospital-based blood transfusion services in low-income and middle-income countries: a cross-sectional international survey

Influence of donor age, sex and ethnicity on high‐titre anti‐A and ‐B: Review of 6 million donations from two national blood providers

The Las Vegas mass shooting: An analysis of blood component administration and blood bank donations

Supplemental findings of the 2017 National Blood Collection and Utilization Survey

How safe is blood, really?

Slowing decline in blood collection and transfusion in the United States – 2017

Complications of blood donation reported to haemovigilance systems: analysis of eleven years of international surveillance

The future of blood services amid a tight balance between the supply and demand of blood products: Perspectives from the ISBT Young Professional Council